Thus, treatment with statins, which increase endothelium-derived NO production and subsequent platelet cGMP production, in combination with PDE5 inhibition by dipyridamole may have a preventative effect on cardiovascular disease without increased risk for bleeding. This evidence concerns the gene PDE5A and cardiovascular disorder.